These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7970091)

  • 1. Plasma endothelin in haemodialysis patients treated with recombinant human erythropoietin.
    Brunet P; Lorec AM; Leonetti F; Roubicek C; Jaber K; Roux F; Berland Y
    Nephrol Dial Transplant; 1994; 9(6):650-4. PubMed ID: 7970091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute effects of recombinant human erythropoietin on plasma levels of proendothelin-1 and endothelin-1 in haemodialysis patients.
    Kang DH; Yoon KI; Han DS
    Nephrol Dial Transplant; 1998 Nov; 13(11):2877-83. PubMed ID: 9829494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma concentrations of immunoreactive-endothelin in patients with chronic renal failure treated with recombinant human erythropoietin.
    Takahashi K; Totsune K; Imai Y; Sone M; Nozuki M; Murakami O; Sekino H; Mouri T
    Clin Sci (Lond); 1993 Jan; 84(1):47-50. PubMed ID: 8382133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous erythropoietin (rHuEPO) administration increases plasma endothelin and blood pressure in hemodialysis patients.
    Carlini R; Obialo CI; Rothstein M
    Am J Hypertens; 1993 Feb; 6(2):103-7. PubMed ID: 8471228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for amelioration of endothelial cell dysfunction by erythropoietin therapy in predialysis patients.
    Kuriyama S; Hopp L; Yoshida H; Hikita M; Tomonari H; Hashimoto T; Sakai O
    Am J Hypertens; 1996 May; 9(5):426-31. PubMed ID: 8735172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of subcutaneous and intraperitoneal administration of recombinant human erythropoietin on blood pressure and vasoactive hormones in patients on continuous ambulatory peritoneal dialysis.
    Lai KN; Lui SF; Leung JC; Law E; Nicholls MG
    Nephron; 1991; 57(4):394-400. PubMed ID: 1828543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased endothelin: nitric oxide ratio is associated with erythropoietin-induced hypertension in hemodialysis patients.
    Shimada N; Saka S; Sekizuka K; Tanaka A; Takahashi Y; Nakamura T; Ebihara I; Koide H
    Ren Fail; 2003 Jul; 25(4):569-78. PubMed ID: 12911161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemodynamic effect of recombinant human erythropoietin on hypotensive haemodialysis patients.
    Onoyama K; Hori K; Osato S; Fujishima M
    Nephrol Dial Transplant; 1991; 6(8):562-5. PubMed ID: 1956555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoietin enhances vascular responsiveness to norepinephrine in renal failure.
    Hand MF; Haynes WG; Johnstone HA; Anderton JL; Webb DJ
    Kidney Int; 1995 Sep; 48(3):806-13. PubMed ID: 7474668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin for anaemia in haemodialysis patients: results of a maintenance study (the Canadian Erythropoietin Study Group).
    Muirhead N; Laupacis A; Wong C
    Nephrol Dial Transplant; 1992; 7(8):811-6. PubMed ID: 1325613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aluminium interference in the treatment of haemodialysis patients with recombinant human erythropoietin.
    Casati S; Castelnovo C; Campise M; Ponticelli C
    Nephrol Dial Transplant; 1990; 5(6):441-3. PubMed ID: 2122321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma endothelin levels and blood pressure in hemodialysis and in CAPD patients. Effect of subcutaneous erythropoietin replacement therapy.
    Lebel M; Grose JH; Kingma I; Langlois S
    Clin Exp Hypertens; 1994 Sep; 16(5):565-75. PubMed ID: 7951163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood pressure response to erythropoietin injection in hemodialysis and predialysis patients.
    Miyashita K; Tojo A; Kimura K; Goto A; Omata M; Nishiyama K; Fujita T
    Hypertens Res; 2004 Feb; 27(2):79-84. PubMed ID: 15005270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemodialysis efficiency after long-term treatment with recombinant human erythropoietin.
    Casati S; Campise M; Crepaldi M; Lobo J; Graziani G; Ponticelli C
    Nephrol Dial Transplant; 1989; 4(8):718-20. PubMed ID: 2510080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impacts of recombinant human erythropoietin treatment during predialysis periods on the progression of chronic kidney disease in a large-scale cohort study (Co-JET study).
    Akizawa T; Saito A; Gejyo F; Suzuki M; Nishizawa Y; Tomino Y; Tsubakihara Y; Akiba T; Hirakata H; Watanabe Y; Kawanishi H; Bessho M; Udagawa Y; Aoki K; Uemura Y; Ohashi Y;
    Ther Apher Dial; 2014 Apr; 18(2):140-8. PubMed ID: 24720404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of the 6-month anemia therapy with erythropoietin on renal function and some hemodynamic parameters in predialysis patients.
    Tomczak-Watras W; Strózecki P; Zuchora Z; Szefer J; Manitius J
    Pol Arch Med Wewn; 2009; 119(1-2):45-51. PubMed ID: 19341178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid and apolipoprotein patterns during erythropoietin therapy: roles of erythropoietin, route of administration, and diet.
    Allegra V; Martimbianco L; Vasile A
    Nephrol Dial Transplant; 1997 May; 12(5):924-32. PubMed ID: 9175044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does long-term treatment of renal anaemia with recombinant erythropoietin influence oxidative stress in haemodialysed patients?
    Sommerburg O; Grune T; Hampl H; Riedel E; van Kuijk FJ; Ehrich JH; Siems WG
    Nephrol Dial Transplant; 1998 Oct; 13(10):2583-7. PubMed ID: 9794564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in endothelial vasoactive substances under recombinant human erythropoietin therapy in hemodialysis patients.
    Takayama K; Nagai T; Kinugasa E; Akizawa T; Koshikawa S
    ASAIO Trans; 1991; 37(3):M187-8. PubMed ID: 1836334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcutaneous erythropoietin administration in predialysis patients: a single centre prospective study.
    Branger B; Vécina F; Zabadani B; Balducchi JP; Fourcade J
    Nephrol Dial Transplant; 1995; 10 Suppl 6():36-9. PubMed ID: 8524492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.